Sangamo Therapeutics Inc (NASDAQ:SGMO) does about 2.39M shares in volume on a normal day but saw 1348410 shares change hands in Friday trading. The company now has a market cap of 110.67M USD. Its current market price is $0.54, marking a decrease of -0.33% compared to the previous close of $0.55. The 52 week high reached by this stock is $1.80 whilst the lowest price level in 52 weeks is $0.29.
Sangamo Therapeutics Inc (SGMO) has a 20-day trading average at $0.6553 and the current price is -69.89% off the 52-week high compared with 86.67% distance from its 52-week low. The 50-day simple moving average of the closing price is $0.7975 and its 200-day simple moving average is $0.7507. If we look at the stock’s price movements over the week, volatility stands at 8.83%, which increases to 12.99% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 38.25 to suggest the stock is neutral.
The consensus objective for the share price is $3.50, suggesting that the stock has a potential upside of 84.57% over the period.
The company shares received a number of brokerage firm price updates over the past month, with the latest being on November 03, 2023 when RBC Capital Mkts downgraded the stock to “Sector Perform” and issued a price target of between $6 and $2. BofA Securities also downgraded the stock to “Underperform” from Neutral on April 28, 2023 at a price target of $5-$1.50. Wedbush upgraded its price target at $16.
Sangamo Therapeutics Inc (SGMO) stock is down -3.17% over the week and -30.79% over the past month. Its price is 0.02% year-to-date and -60.04% over the past year.
To reach the target analysts have set, the stock logically needs to grow 84.57 percent from here.
The company has a return on investment of -221.50% and return on equity of -136.48%. The beta has a value of 1.37. Price to book ratio is 1.17 and price to sales ratio is 0.63.
